News Catalent, Inc. Berne S.E.

Stocks

0C8

US1488061029

Delayed Berne S.E. Other stock markets			5-day change	1st Jan Change
- ^CHF	-.--%		-.--%	-

07-07	Nanoscope Therapeutics Expands Partnership With Catalent to Support Late-Phase Development and Commercial Supply of MCO-010	CI
06-16	Catalent Launches Qai Enterprise AI Tool for Quality Management System Processes	CI

All News

Mentions Relevance

07-07	Nanoscope Therapeutics Expands Partnership With Catalent to Support Late-Phase Development and Commercial Supply of MCO-010	CI
06-16	Catalent Launches Qai Enterprise AI Tool for Quality Management System Processes	CI
05-13	Elpida Therapeutics and Catalent Enter Strategic Partnership for Late-Phase Aav Manufacturing	CI
04-09	Cartherics Pty Ltd and Catalent Inc Expand Commercial License Agreement	CI
03-11	Gelmedix and Catalent Enter Global Partnership for Development and Clinical Manufacturing of Ipsc-Derived Cell Therapies in Ocular and Retinal Diseases	CI
01-12	Smartcella Holding AB and Catalent, Inc. Sign Nonexclusive License Agreement for Gmp Ipscs	CI
11-04	Catalent, Inc.'s SMARTag ADC Pipeline and New Enhanced Conjugates Offering Featured at 16th World ADC San Diego	CI
25-09-04	Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research	CI
25-04-23	Silexion Therapeutics Announces Collaboration with Global Therapeutics Leader Catalent on Advanced siRNA Formulation Development & Clinical Manufacturing Activities	CI
25-04-15	Lisata Therapeutics, Inc. Announces Research License with Catalent, Inc	CI
25-02-20	Catalent, Inc. Appoints Susan Mahony, Marie-France Tschudin and Tim Walbert to Its Board of Directors	CI
25-02-19	Experts explore the future of iPSC-based cell therapies	AQ
25-02-03	Ardena Holding NV completed the acquisition of Oral Solids Development and Small-Scale Manufacturing Facility in Somerset, NJ from Catalent, Inc..	CI
25-02-03	Ardena Holding NV acquired Drug product manufacturing facility in Somerset, New Jersey of Catalent, Inc.	CI
25-02-03	Ardena Holding NV acquired Drug product manufacturing facility in Somerset, New Jersey of Catalent, Inc.	CI
24-12-22	Catalent, Inc.(NYSE:CTLT) dropped from S&P 500 Value	CI
24-12-22	Catalent, Inc.(NYSE:CTLT) dropped from S&P 500 Ex-Financials, Real Estate, Utilities and Transportation Index	CI
24-12-22	Catalent, Inc.(NYSE:CTLT) dropped from S&P 500 Equal Weighted	CI
24-12-22	Catalent, Inc.(NYSE:CTLT) dropped from S&P 500 - Pharmaceuticals	CI
24-12-22	Catalent, Inc.(NYSE:CTLT) dropped from S&P Global 1200	CI
24-12-22	Catalent, Inc.(NYSE:CTLT) dropped from S&P 500 Health Care	CI
24-12-22	Catalent, Inc.(NYSE:CTLT) dropped from S&P 500	CI
24-12-22	Catalent, Inc.(NYSE:CTLT) dropped from S&P Composite 1500	CI
24-12-22	Catalent, Inc.(NYSE:CTLT) dropped from S&P Pharmaceuticals Select Industry Index	CI
24-12-22	Catalent, Inc.(NYSE:CTLT) dropped from S&P TMI Index	CI